TENX TENAX THERAPEUTICS INC
Permanent stock page ↗Health Care · Russell 2000
Next earnings: not announced yet
What 13 analyst firms say about TENAX THERAPEUTICS INC: their latest ratings, price targets and how far the stock is from them. How it works
Analyst window: Latest analyst report within last 1 year
Analyst view · last 1Y
11 rated views · 14 analyst/firm records · 13 firms
Radar score
- Russell 2000 · Top Picks · 6MNot scored · Price below 5 USD
- Russell 2000 · Safest consensus · 6MNot scored · Price below 5 USD
Recent analyst activity · last 90 days
Our tracked history has 13 reports on TENX from 11 analyst firms in the last 90 days (13 firms in the past year).
Comparing each firm's latest target with its previous one: 2 lowered it, 1 left it unchanged and 3 have their first observed target in the past year.
Ratings, latest available report against the previous one: 0 upgrades and 2 downgrades.
Latest observed target change: Chardan Capital lowered its target from $27.00 (set 31 Jul 2026) to $5.00 on 11 Aug 2026.
Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.
| Firm | Analyst | Latest rating | Report date | Latest target (USD) |
|---|---|---|---|---|
| Canaccord Genuity | Angela Qian | Buy | 28 Jul 2026 | Conflicting reports · excluded |
| Canaccord Genuity | Whitney Ijem | Buy | 11 Aug 2026 | 4.00 USD |
| Cantor Fitzgerald | Olivia Brayer | Buy | 10 Sep 2026 | 35.00 USD · 24 Jun 2026 |
| Chardan Capital Markets | Gautam Chukka | Hold | 11 Aug 2026 | 5.00 USD |
| Evercore ISI | Gavin Clark-Gartner | Hold | 10 Aug 2026 | 5.00 USD |
| Guggenheim | Seamus Fernandez | Hold | 31 Aug 2026 | — |
| Leerink Partners | David Risinger | ConflictConflicting reports · excluded | 11 Aug 2026 | 4.00 USD |
| Lifesci Capital | Gaurav Maini | Buy | 6 Jul 2026 | 35.00 USD |
| Piper Sandler | Yasmeen Rahimi | Buy | 15 Sep 2026 | 50.00 USD · 12 Jun 2026 |
| Roth Capital | Jonathan Aschoff | ConflictConflicting reports · excluded | 10 Aug 2026 | 5.00 USD |
| UBS | Unnamed analyst | Hold | 31 Aug 2026 | — |
| Weiss Ratings | Unnamed analyst | — | 14 Sep 2026 | — |
| William Blair | Matt Phipps | Hold | 10 Aug 2026 | — |
| Data feed RESEARCH | Research Team | Hold | 15 Jun 2026 | — |
Partial coverage · checked 6 Nov (6 Nov 2026, 03:43 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.